Nurse Practitioner, Family · Conway, SC
NPI
1154669265
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
847 Farrar Dr Unit 2
Conway, SC, 29526
Phone (843) 234-9700
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
843 services
Medicare patients, 2024
320
Average age 72
Drug cost, 2024
$3.5M
7,303 prescriptions
Company payments, 2025
$1,087
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel M Collins was code 99214 (office e&m - established), 478 times for 244 patients. In total Rachel M Collins billed 843 services in 8 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 478 | 244 | $54.79 | $26K |
| 95251 Test - Miscellaneous | Facility | 139 | 65 | $20.03 | $2,785 |
| 99213 Office E&M - Established | Facility | 116 | 98 | $40.10 | $4,651 |
| 99204 Office E&M - New | Facility | 74 | 74 | $71.94 | $5,324 |
By year: 2022 $72K for 1,547 services; 2023 $60K for 1,178 services; 2024 $39K for 843 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel M Collins prescribed most often to Medicare patients was Ozempic (Semaglutide), with 551 prescriptions and refills. In total Rachel M Collins wrote 7,303 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 551 | 1,040 | 148 | $985K |
| Levothyroxine Sodium Generic | 496 | 1,364 | 187 | $5,119 |
| Jardiance Empagliflozin | 338 | 675 | 97 | $397K |
| Metformin Hcl Generic | 287 | 814 | 105 | $2,621 |
| Mounjaro Tirzepatide | 251 | 347 | 58 | $365K |
| Metformin Hcl Er Metformin Hcl | 191 | 538 | 76 | $3,388 |
| Tresiba Flextouch U-200 Insulin Degludec | 191 | 451 | 64 | $261K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 180 | 456 | 75 | $35K |
| Rosuvastatin Calcium Generic | 177 | 482 | 79 | $2,926 |
| Synthroid Levothyroxine Sodium | 163 | 377 | 46 | $12K |
| Atorvastatin Calcium Generic | 150 | 422 | 63 | $2,627 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 138 | 394 | 65 | $17K |
| Novolog Flexpen Insulin Aspart | 135 | 320 | 56 | $55K |
| Gabapentin Generic | 129 | 261 | 39 | $2,653 |
| Farxiga Dapagliflozin Propanediol | 125 | 304 | 47 | $166K |
Brand drugs: 3,387 claims; generic drugs: 3,409 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel M Collins $1,087 ($1,087 in general payments such as food, travel and fees) from 19 companies. The largest payer was Lilly USA, LLC with $160.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 5 | $160 |
| Novo Nordisk Inc NVO | 4 | $95.41 |
| Xeris Pharmaceuticals, Inc. | 4 | $88.98 |
| Sanofi-Aventis U.S. LLC SNY | 2 | $87.42 |
| Beta Bionics, Inc. BBNX | 3 | $79.34 |
| Amgen Inc. AMGN | 4 | $73.81 |
| Corcept Therapeutics CORT | 3 | $59.34 |
| Ascensia Diabetes Care Us Inc. | 2 | $53.62 |
| Radius Health, Inc. | 2 | $53.36 |
| Medtronic, Inc. MDT | 3 | $49.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.